TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
1.940
-0.040 (-2.02%)
At close: Dec 5, 2025, 4:00 PM EST
1.980
+0.040 (2.06%)
After-hours: Dec 5, 2025, 7:50 PM EST

TuHURA Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22
Net Income
-29.29-21.68-29.32-9.37
Depreciation & Amortization
0.070.120.180.37
Other Amortization
0.171.280.01-
Asset Writedown & Restructuring Costs
--16.22-
Stock-Based Compensation
5.361.960.480.22
Other Operating Activities
0.190.31--0.29
Change in Accounts Payable
-1.513.640.341.85
Change in Other Net Operating Assets
0.03-0.360.15-0.29
Operating Cash Flow
-24.67-14.73-11.95-7.51
Capital Expenditures
-0.07-0.06-1.3-0.04
Cash Acquisitions
-2.06-5.99--
Investing Cash Flow
-2.13-6.05-1.3-0.04
Long-Term Debt Issued
-28.572.69-
Long-Term Debt Repaid
--0.8--0.35
Net Debt Issued (Repaid)
-1.3727.772.69-0.35
Issuance of Common Stock
15.757.05--
Repurchase of Common Stock
---0.02-
Other Financing Activities
-4.46-5.05--
Financing Cash Flow
9.9129.772.6616.25
Net Cash Flow
-16.98.99-10.598.71
Free Cash Flow
-24.74-14.79-13.25-7.54
Free Cash Flow Per Share
-0.56-0.79-1.11-
Levered Free Cash Flow
-1.44-15.19-8.29-
Unlevered Free Cash Flow
-1.27-13.88-8.29-
Change in Working Capital
-1.483.290.491.56
Updated Nov 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q